Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4461
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [1] RISK OF INFECTIONS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
  • [2] RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
  • [3] Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Mendes, Diogo
    Penedones, Ana
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 130 - 130
  • [4] JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 86 - 86
  • [5] The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E407 - E414
  • [6] Comparative Efficacy and Safety of JAK Inhibitors in the Management of Rheumatoid Arthritis: A Network Meta-Analysis
    Almoallim, Hani M.
    Omair, Mohammed A.
    Ahmed, Sameh A.
    Vidyasagar, Kota
    Sawaf, Bisher
    Yassin, Mohamed A.
    PHARMACEUTICALS, 2025, 18 (02)
  • [7] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2020, 37 : 2356 - 2372
  • [8] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2356 - 2372
  • [9] Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
    Wang, Faping
    Tang, Xiaoju
    Zhu, Min
    Mao, Hui
    Wan, Huajing
    Luo, Fengming
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [10] Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 589 - 590
12345